Cargando…
A 3 year post‐intervention follow‐up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
AIMS: Vitamin D supplementation is widely used in the clinical setting, but its effects on mortality and cardiovascular outcomes in patients with heart failure are unclear. This paper reports outcome data that were collected during follow‐up of 3 years after closure of the EVITA trial (a 3 year rand...
Autores principales: | Zittermann, Armin, Ernst, Jana B., Prokop, Sylvana, Fuchs, Uwe, Berthold, Heiner K., Gouni‐Berthold, Ioanna, Gummert, Jan F., Pilz, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755020/ https://www.ncbi.nlm.nih.gov/pubmed/32915512 http://dx.doi.org/10.1002/ehf2.12953 |
Ejemplares similares
-
Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
por: Zittermann, Armin, et al.
Publicado: (2018) -
Randomized supplementation of 4000 IU vitamin D(3) daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
por: Ernst, J. B., et al.
Publicado: (2017) -
The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2020) -
Correction: The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2021) -
Reply to Meshkini et al.
por: Zittermann, Armin, et al.
Publicado: (2021)